Bulletin
Investor Alert

Karyopharm Therapeutics Inc.

NAS: KPTI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210512150/composite

$

16.10

Change

-0.22 -1.35%

Volume

Volume 90,113

Sep 18, 2020, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210512150/composite

Previous close

$ 16.09

$ 16.32

Change

+0.23 +1.43%

Day low

Day high

$15.87

$16.48

Open
Open: 16.42

52 week low

52 week high

$8.92

$29.61

Open

Market cap

$1.20B

Average volume

1.47M

P/E ratio

N/A

Rev. per Employee

$91,374

EPS

-2.84

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/kpti

MarketWatch News on KPTI

  1. Charting a tenuous recovery attempt, S&P 500 maintains major support

    12:19 p.m. March 20, 2020

    - Michael Ashbaugh

  2. Karyopharm Therapeutics downgraded to neutral from outperform at Wedbush

    9:18 a.m. Jan. 17, 2020

    - Tomi Kilgore

  3. Karyopharm Therapeutics upgraded to overweight from neutral at J.P. Morgan

    8:03 a.m. July 23, 2019

    - Tomi Kilgore

  4. Karyopharm Stock Is Soaring for a Second Day on a Key FDA Approval

    10:14 a.m. July 5, 2019

    - Barron's Online

  5. Karyopharm Therapeutics stock price target raised to $11 from $6 at Wedbush

    7:57 a.m. July 5, 2019

    - Tomi Kilgore

  6. Karyopharm Therapeutics stock price target raised to $8 vs. $7 at JPMorgan

    8:56 a.m. June 27, 2019

    - Ciara Linnane

  7. Karyopharm Therapeutics stock price target cut to $7 from $21 at J.P. Morgan

    8:13 a.m. March 1, 2019

    - Tomi Kilgore

  8. Karyopharm Therapeutics downgraded to neutral from overweight at J.P. Morgan

    8:13 a.m. March 1, 2019

    - Tomi Kilgore

  9. Karyopharm Therapeutics started at buy with $23 stock price target at B. Riley FBR

    1:51 p.m. Nov. 30, 2018

    - Tomi Kilgore

  10. Papa John’s and 3 Other Small-Cap Value Plays

    2:17 p.m. Aug. 7, 2018

    - Barron's Online

  11. Karyopharm Therapeutics shares jump 9% premarket

    7:04 a.m. April 10, 2018

    - Ciara Linnane

  12. Karyopharm Therapeutics wins FDA fast track designation for multiple myeloma treatment

    7:04 a.m. April 10, 2018

    - Ciara Linnane

  13. Starboard Value Likes comScore’s Potential

    12:12 a.m. Nov. 11, 2017

    - Barron's Online

  14. Top Biotech Picks: “The Strong Will Survive And Thrive”

    3:44 p.m. Jan. 5, 2017

    - Barrons Blogs

  15. 4 stocks to watch

    2:06 p.m. Aug. 31, 2016

    - The Trading Deck

  16. Loading more headlines...
/news/nonmarketwatch/company/us/kpti

Other News on KPTI

  1. Oncology Stocks Area Trading Materially Lower The Last 2 Months

    8:00 a.m. Aug. 24, 2020

    - Seeking Alpha

  2. 10-Q: KARYOPHARM THERAPEUTICS INC.

    4:15 p.m. Aug. 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Wall Street Analysts Are Bullish on Top Healthcare Picks

    10:02 a.m. July 20, 2020

    - SmarterAnalyst

  4. Karyopharm Therapeutics (KPTI) Received its Third Buy in a Row

    9:51 a.m. July 17, 2020

    - SmarterAnalyst

  5. Karyopharm teams up with NCI to advance Xpovio research

    8:49 a.m. July 17, 2020

    - Seeking Alpha

  6. Denovo Biopharma's enzastaurin Fast Track'd for brain tumor

    8:18 a.m. July 17, 2020

    - Seeking Alpha

  7. Karyopharm sees Q2 Xpovio sales of $18.5M

    7:43 a.m. July 14, 2020

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/kpti

Press Releases on KPTI

  1. Diffuse Large B-Cell Lymphoma Emerging Drugs, 2020

    2:28 p.m. Sept. 2, 2020

    - ABNewswire

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.